Principal firms disclose 9.9% Sabra Health Care REIT stake in 13G/A (SBRA)
Rhea-AI Filing Summary
Principal Real Estate Investors LLC and Principal Global Investors report beneficial ownership of 24,472,080 shares, or 9.9%, of Sabra Health Care REIT, Inc.
The filing shows no sole voting or dispositive power, with all 24,472,080 shares held with shared voting and shared dispositive power. Principal Real Estate Investors accounts for 21,331,583 shares, or 8.6% of the class, and Principal Global Investors for 3,140,497 shares, or 1.3%. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Sabra.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in Sabra Health Care REIT (SBRA) is reported in this Schedule 13G/A?
The filing reports beneficial ownership of 24,472,080 Sabra shares, representing 9.9% of the common stock. This total combines holdings attributed to Principal Real Estate Investors LLC and Principal Global Investors, with all shares held with shared voting and shared dispositive power as of December 31, 2025.
What is Principal Global Investors’ reported position in Sabra Health Care REIT (SBRA)?
Principal Global Investors reports beneficial ownership of 3,140,497 Sabra common shares, representing 1.3% of the outstanding class. The filing states these shares are held with shared voting and shared dispositive power, with no sole voting or sole dispositive power over the shares.
Which entities jointly filed this Schedule 13G/A for Sabra Health Care REIT (SBRA)?
The Schedule 13G/A is filed jointly by Principal Real Estate Investors LLC and Principal Global Investors LLC. The document notes a Joint Filing Agreement, identified as Exhibit 99.1, under which these Delaware-organized entities report their combined beneficial ownership in Sabra.
As of what date is the reported Sabra (SBRA) ownership information effective in this filing?
The ownership information in this Schedule 13G/A is effective as of December 31, 2025. That date is identified as the event requiring the filing, and the reported share amounts and percentage of class, including the 9.9% aggregate stake, are stated as of that date.